Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001812
Filing Date
2025-08-14
Accepted
2025-08-14 16:08:05
Documents
55
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tdac-20250630x10q.htm   iXBRL 10-Q 923108
2 EX-31.1 tdac-20250630xex31d1.htm EX-31.1 11989
3 EX-31.2 tdac-20250630xex31d2.htm EX-31.2 10937
4 EX-32.1 tdac-20250630xex32d1.htm EX-32.1 5299
5 EX-32.2 tdac-20250630xex32d2.htm EX-32.2 5153
  Complete submission text file 0001410578-25-001812.txt   4973718

Data Files

Seq Description Document Type Size
6 EX-101.SCH tdac-20250630.xsd EX-101.SCH 44960
7 EX-101.CAL tdac-20250630_cal.xml EX-101.CAL 17015
8 EX-101.DEF tdac-20250630_def.xml EX-101.DEF 177304
9 EX-101.LAB tdac-20250630_lab.xml EX-101.LAB 316658
10 EX-101.PRE tdac-20250630_pre.xml EX-101.PRE 258365
58 EXTRACTED XBRL INSTANCE DOCUMENT tdac-20250630x10q_htm.xml XML 851192
Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Filer) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42451 | Film No.: 251218944
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)